Tirsdag 26. september

09.00 - 09.10

Velkommen // Christian Qvigstad

MYELOMATOSE

Chair: Fredrik Schjesvold

09.10 - 10.10

CAR-T-cell therapy and bispecific antibodies in myeloma // Tom Martin

10.10 - 10.20

Pause

10.20 - 10.50

CAR-T and bispecific antibodies in multiple myeloma - experiences from Oslo // Ingerid Abrahamsen

10.50 - 11.25

Pause

11.25 - 12.00

Panel discussion: CAR-T and bispecifics – experiences, tips and tricks // Ingerid Abrahamsen // Tom Martin

12.00 - 13.00

Lunsj

ALLOTRANSPLANT MYELOMATOSE OG MGUS ASSOSIERTE SYKDOMMER

Chair: Tor H. Tvedt

13.00 - 13.30

RAS mutations in myeloma // Hanne Nordseth

13.30 - 13.50

Reimbursement of novel drugs for multiple myeloma // Fredrik Schjesvold

13.50 - 14.00

Pause

14.00 - 14.30

Monklonalt IgM + komplement = sykdom // Geir Erland Tjønnfjord

14.30 - 14.40

New studies in CAD // Tor H. Tvedt

14.40 - 14.50

Nytt fra styret/etterutdanning // Hege Frøen

14.50 - 15.10

Pause

MDS

Chair: Tor H. Tvedt

15.10 - 16.00

Allotransplantsjon for CMML // Nicolaus Kröger (Digitalt)

16.00 - 16.10

Pause

AML

Chair: Tor H. Tvedt

16.10 - 16.55

IDH inhibitors in AML // Bas Wouters

16.55 - 17.05

Pause

17.05 - 18.00

FLT3 inhibitors AML //

19.00

Middag

VTE

Chair: Ellen Brodin

08.00 - 08.10

Velkommen

08.10 - 08.45

The new anticoagulants // Peter Verhamme

08.45 - 09.45

Reversal of factor XI inhibition // Pål Andre Holme

09.45 - 10.15

Pause

AML

Chair: Tor H. Tvedt

10.15 - 11.00

The ASAP trial: role of remission induction chemotherapy before alloHCT in R/R AML // Johannes Schetelig (Digitalt)

11.00 - 11.10

Pause

11.10 - 12.10

Gene therapy in thalassemia // Andreas Glenthøj

12.10 - 13.10

Lunsj

HEMOGLOBINOPATIER OG BENIGN HEMATOLOGI

Chair: Nina Schultz

13.10 - 13.55

Current and future alternative non-transpalnt therapies for thalassemia // Ali Taher (Digitalt)

13.55 - 14.25

Pause

Complement

Chair: Geir Tjønnfjord

14.25 - 15.10

C1 Esterase Inhibitor // Erik Waage Nielsen // Robert Brudevold

15.10 - 15.20

Pause

15.20 - 16.15

Therapeutic Targeting of the Complement System // Tom Eirik Mollnes

16.15 - 16.30

Avslutning